Taro Pharmaceutical Industries Ltd. (TARO)
TAROPrice: $42.98
Fair Value: 🔒
🔒score
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingre... more
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures,... more
Description
Shares
| Market Cap | $1.62B | Exchange | NYSE |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | IL | CEO | Uday V. Baldota |
| IPO Date | 1982-09-14 | CAGR | 0.12% |
| Employees | 1,554 | Website | www.taro.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
TARO chart loading...
Fundamentals
Technicals
| Enterprise Value | $1.22B | P/E Ratio | 30.05 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 2.57 | P/B Ratio | 0.9 |
| P/CF Ratio | 12.2 | P/FCF Ratio | 20.66 |
| EPS | $1.43 | EPS Growth 1Y | 116.48% |
| EPS Growth 3Y | — | EPS Growth 5Y | -80.08% |
| Revenue Growth 1Y | 9.81% | Gross Margin | 0.48% |
| Operating Margin | 0.03% | Profit Margin | 0.09% |
| ROE | 0.03% | ROA | 0.02% |
| ROCE | 0.01% | Current Ratio | 3.61 |
| Quick Ratio | 3.04 | Cash Ratio | 1 |
| Debt/Equity | — | Interest Coverage | — |
| Altman Z Score | 3.49 | Piotroski Score | 7 |